Followers | 168 |
Posts | 23923 |
Boards Moderated | 0 |
Alias Born | 05/13/2014 |
Monday, April 22, 2024 7:32:10 PM
ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
March 26, 2024
Dear Stockholder:
This Information Statement is being furnished to holders of shares of common stock, par value $0.00001 per share (the “Common Stock”), of Artificial Intelligence Technology Solutions Inc. (the “Company”) with respect to the following item (the “Corporate Action”):
1. The approval of a Certificate of Amendment to the Company’s Articles of Incorporation to increase its authorized common stock by two billion five hundred million (2,500,000,000) shares, from ten billion (10,000,000,000) total authorized common stock shares to a total of twelve billion five hundred million (12,500,000,000) common stock shares The Certificate of Amendment will not be filed until at least 20 days after we file the Definitive Information Statement with the Securities and Exchange Commission and deliver the Definitive Information Statement to our shareholders of record.
This Information Statement is being furnished to holders of shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company with respect to the following items (the “Corporate Action”):
1. The approval of a Certificate of Amendment to the Company’s Articles of Incorporation to increase its authorized common stock by two billion five hundred million (2,500,000,000) common stock shares to a total of twelve billion five hundred million common stock shares (12,500,000,000). The Certificate of Amendment will not be filed until at least 20 days after we file the Information Statement with the Securities and Exchange Commission and deliver the Definitive Information Statement to our shareholders of record.
The Corporate Action items was approved by consent shareholder vote holding a majority of our voting power on March 12, 2024 by written consent in lieu of an annual meeting of shareholders.
This Information Statement describes the purpose and provisions of the Corporate Action and provides additional information about the Corporation.
Recent AITX News
- Shares of this Innovative AI Solutions Firm Rip on Updated Pricing • AllPennyStocks.com • 05/06/2024 06:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:10:24 AM
- Shares Moving Up For AI SAAS Firm on News of an Initial Order • AllPennyStocks.com • 04/11/2024 03:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:04:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 11:01:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:09:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 11:05:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:02:46 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/07/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 11:05:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 11:02:25 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:03:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:01:53 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/19/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:04:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 08:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:05:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:02:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 11:03:03 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM